Literature DB >> 24251858

Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis.

Stacey L Martiniano1, Marci K Sontag, Charles L Daley, Jerry A Nick, Scott D Sagel.   

Abstract

RATIONALE: Little is known about outcomes of infection with nontuberculous mycobacteria (NTM) in cystic fibrosis (CF) or about the significance of a positive NTM culture. Determining which patients are at risk for active NTM disease is clinically valuable.
OBJECTIVES: To examine the clinical course of subjects with CF with an initial positive NTM culture and identify characteristics associated with active NTM disease.
METHODS: We performed a retrospective study of pediatric and adult subjects with CF with at least one positive NTM culture at the Colorado CF Center from 2000 to 2010.
MEASUREMENTS AND MAIN RESULTS: Mycobacterium avium complex was the first identified NTM in the majority of subjects (73%). The frequency of growing a second NTM species was 26% at 5 years. Clinical characteristics and distribution of NTM species between pediatric and adult subjects were similar except for differences in baseline FEV1 (89% vs. 71%; P < 0.001) and coinfection with Pseudomonas aeruginosa (33% vs. 55%; P = 0.04). Over 60% of subjects had transient or persistent infection but not active NTM disease. Subjects who developed active NTM disease were distinguished from those with transient or persistent infection, respectively, by FEV1 at the time of first positive NTM culture (72% vs. 84 or 86%; P = 0.02) and FEV1 decline in the prior year (-5.8%/yr vs. -0.7%/yr [P = 0.009] or -0.4%/yr [P = 0.001]).
CONCLUSIONS: The majority of patients with CF with a first positive NTM culture do not progress to active disease. Lower lung function and accelerated lung function decline appear to be indicators of the significance of an initial positive NTM culture.

Entities:  

Mesh:

Year:  2014        PMID: 24251858      PMCID: PMC3972987          DOI: 10.1513/AnnalsATS.201309-310OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  39 in total

1.  A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease.

Authors:  Yoshihiro Kobashi; Toshiharu Matsushima; Mikio Oka
Journal:  Respir Med       Date:  2006-06-05       Impact factor: 3.415

2.  Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.

Authors:  Kyeongman Jeon; O Jung Kwon; Nam Yong Lee; Bum-Joon Kim; Yoon-Hoh Kook; Seung-Heon Lee; Young Kil Park; Chang Ki Kim; Won-Jung Koh
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

3.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

4.  Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease.

Authors:  Won-Jung Koh; Byeong-Ho Jeong; Kyeongman Jeon; Nam Yong Lee; Kyung Soo Lee; Sook Young Woo; Sung Jae Shin; O Jung Kwon
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

5.  Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.

Authors:  Bodil E Jönsson; Marita Gilljam; Anders Lindblad; Malin Ridell; Agnes E Wold; Christina Welinder-Olsson
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

6.  Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients.

Authors:  Emilie Catherinot; Anne-Laure Roux; Marie-Anne Vibet; Gil Bellis; Lydie Lemonnier; Evelyne Le Roux; Claire Bernède-Bauduin; Muriel Le Bourgeois; Jean-Louis Herrmann; Didier Guillemot; Jean-Louis Gaillard
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

7.  Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.

Authors:  Won-Jung Koh; Kyeongman Jeon; Nam Yong Lee; Bum-Joon Kim; Yoon-Hoh Kook; Seung-Heon Lee; Young Kil Park; Chang Ki Kim; Sung Jae Shin; Gwen A Huitt; Charles L Daley; O Jung Kwon
Journal:  Am J Respir Crit Care Med       Date:  2010-09-10       Impact factor: 21.405

8.  Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france.

Authors:  Anne-Laure Roux; Emilie Catherinot; Fabienne Ripoll; Nathalie Soismier; Edouard Macheras; Sophie Ravilly; Gil Bellis; Marie-Anne Vibet; Evelyne Le Roux; Lydie Lemonnier; Cristina Gutierrez; Véronique Vincent; Brigitte Fauroux; Martin Rottman; Didier Guillemot; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

9.  Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis.

Authors:  Alison M Binder; Jennifer Adjemian; Kenneth N Olivier; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2013-10-01       Impact factor: 21.405

10.  Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations.

Authors:  Emilie Catherinot; Anne-Laure Roux; Marie-Anne Vibet; Gil Bellis; Sophie Ravilly; Lydie Lemonnier; Evelyne Le Roux; Claire Bernède-Bauduin; Muriel Le Bourgeois; Jean-Louis Herrmann; Didier Guillemot; Jean-Louis Gaillard
Journal:  J Cyst Fibros       Date:  2012-07-31       Impact factor: 5.482

View more
  33 in total

Review 1.  Nontuberculous mycobacteria in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  In Kwon Park; Kenneth N Olivier
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

2.  Mycobacterium abscessus Displays Fitness for Fomite Transmission.

Authors:  Kenneth C Malcolm; Silvia M Caceres; Jennifer R Honda; Rebecca M Davidson; L Elaine Epperson; Michael Strong; Edward D Chan; Jerry A Nick
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

3.  Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy.

Authors:  Kerstin Pohl; Xue A Grimm; Silvia M Caceres; Katie R Poch; Noel Rysavy; Milene Saavedra; Jerry A Nick; Kenneth C Malcolm
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

4.  Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway.

Authors:  Prithwiraj De; Anita G Amin; Barbara Graham; Stacey L Martiniano; Silvia M Caceres; Katie R Poch; Marion C Jones; Milene T Saavedra; Kenneth C Malcolm; Jerry A Nick; Delphi Chatterjee
Journal:  J Cyst Fibros       Date:  2020-07-03       Impact factor: 5.482

5.  Distribution and outcomes of infection of Mycobacterium avium complex species in cystic fibrosis.

Authors:  Michelle Azar; Madsen Zimbric; Kerby Shedden; Lindsay J Caverly
Journal:  J Cyst Fibros       Date:  2019-08-06       Impact factor: 5.482

Review 6.  Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights.

Authors:  Pamela J McShane; Jeffrey Glassroth
Journal:  Chest       Date:  2015-12       Impact factor: 9.410

7.  High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase.

Authors:  Paulami Rudra; Kelley Hurst-Hess; Pascal Lappierre; Pallavi Ghosh
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 8.  Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.

Authors:  Stacey L Martiniano; Charles R Esther; Charles S Haworth; Shannon H Kasperbauer; Edith T Zemanick; Lindsay J Caverly
Journal:  Pediatr Pulmonol       Date:  2019-12-10

9.  Low rates of macrolide-resistant Mycobacterium avium complex in cystic fibrosis despite chronic azithromycin therapy.

Authors:  William J Richter; Jan A Nguyen; Andrew E Wu; Mark T Jennings; Noah Lechtzin; Nicole M Parrish; Kevin J Psoter; Keira A Cohen
Journal:  J Cyst Fibros       Date:  2020-09-16       Impact factor: 5.482

10.  Population Genomics of Mycobacterium abscessus from U.S. Cystic Fibrosis Care Centers.

Authors:  Rebecca M Davidson; Nabeeh A Hasan; L Elaine Epperson; Jeanne B Benoit; Sara M Kammlade; Adrah R Levin; Vinicius Calado de Moura; Joshua Hunkins; Natalia Weakly; Sean Beagle; Scott D Sagel; Stacey L Martiniano; Max Salfinger; Charles L Daley; Jerry A Nick; Michael Strong
Journal:  Ann Am Thorac Soc       Date:  2021-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.